• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CHRISTOPH MIETHKE GMBH & CO. KG PAEDIGAV SYSTEM W/PRECHAMB.ON VALVE 4/24; HYDROCEPHALUS MANAGEMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CHRISTOPH MIETHKE GMBH & CO. KG PAEDIGAV SYSTEM W/PRECHAMB.ON VALVE 4/24; HYDROCEPHALUS MANAGEMENT Back to Search Results
Model Number FV304T
Device Problems Improper Flow or Infusion (2954); Infusion or Flow Problem (2964)
Patient Problems Failure of Implant (1924); Patient Problem/Medical Problem (2688)
Event Date 04/08/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).When additional information is received, a follow up report will be submitted.
 
Event Description
It was reported that 3 months and 2 weeks post-operatively the valve became blocked and underdrainage occurred.The device was explanted.Additional information has been requested, however, not yet received.
 
Manufacturer Narrative
Aesculap inc.(importer, registration no.2916714) is submitting this report on behalf of christoph miethke gmbh & co.Kg (manufacturer, registration no.3004721439).Exemption number: e2017044.Investigation: visual inspection no significant deformations or damage of the valve were detected during the visual inspection.Permeability test a permeability test has indicated that the valve has a blockage.Adjustment test this is a fixed pressure valve.An adjustment test is not applicable.Braking force and brake function test this is a fixed pressure valve.A braking force and brake function test is not applicable.Computer controlled test to investigate the claim of over/under-drainage, the opening pressure is measured using a miethke computer controlled testing apparatus which simulates a cerebrospinal fluid flow.The valve is tested in both the horizontal as well as the vertical positions.Because the valve is not permeable, a computer controlled test is not possible.Results it should be noted that the paedigav valve was received dry (i.E.Not submersed in liquid as recommended).The investigation of dry items is not significant due to the affect dry deposits of liquid and blood can have on product performance.In spite of this, we have investigated the valve to the best of our abilities.First we performed a visual inspection of the paedigav valve.No significant deformations or damage of the valve were detected during the visual inspection.Next we tested the permeability of the valve.The valve was shown to have a blockage.Due to the non-permeability of the valve the suspicion of underdrainage was unable to be investigated using our computer controlled simulated flow test.Finally, we have dismantled the valve.Inside the valve we have found significant build-up of substances (likely protein).Based on our investigation, we confirm the presence of occlusion in the valve, likely due to the deposits observed inside the valve.As described in our literature, the problem encountered is one of the known, inevitable risk of hc-therapy by shunt implants.We can exclude a defect at the time of release.The valve met all specifications of the final inspection when release from christoph miethke gmbh & co.Kg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PAEDIGAV SYSTEM W/PRECHAMB.ON VALVE 4/24
Type of Device
HYDROCEPHALUS MANAGEMENT
Manufacturer (Section D)
CHRISTOPH MIETHKE GMBH & CO. KG
2 ulanenweg
potsdam d, 14469
GM  14469
MDR Report Key8592730
MDR Text Key144474096
Report Number3004721439-2019-00102
Device Sequence Number1
Product Code JXG
Combination Product (y/n)N
PMA/PMN Number
K011030
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Type of Report Initial,Followup
Report Date 05/28/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received05/08/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/25/2023
Device Model NumberFV304T
Device Catalogue NumberFV304T
Device Lot Number20038862
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/10/2019
Distributor Facility Aware Date04/26/2019
Device Age7 MO
Date Manufacturer Received04/26/2019
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age12 MO
Patient Weight10
-
-